BP
Boobalan Pachaiyappan Roth Capital Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Reviva Pharmaceuticals
RVPH
$30.1M
| $0.4431 | $3 |
577%
upside
| Buy |
18 Aug ‘25
24 days ago |
|
|
LGVN
2
Longeveron
LGVN
$16.6M
| $0.7950 | $3 |
277%
upside
| Buy |
15 Aug ‘25
27 days ago |
|
3
Gain Therapeutics
GANX
$62.2M
| $1.72 | $6 |
249%
upside
| Buy |
13 Aug ‘25
29 days ago |
|
4
CervoMed
CRVO
$82.8M
| $9.20 | $16 |
74%
upside
| Buy |
12 Aug ‘25
1 month ago |
|
5
Capricor Therapeutics
CAPR
$289M
| $6.44 | $12 |
86%
upside
| Buy |
14 Jul ‘25
1 month ago |
|
|
VRNA
6
Verona Pharma
VRNA
$9.2B
| $106.40 | $116 |
9%
upside
| Buy |
18 Jun ‘25
2 months ago |
|
7
PolyPid
PYPD
$54.8M
| $3.45 | $9 |
161%
upside
| Buy |
18 Jun ‘25
2 months ago |
|
8
Cingulate
CING
$20.8M
| $3.93 | $11 |
180%
upside
| Buy |
19 May ‘25
3 months ago |
|
|
9
CervoMed
CRVO
$82.8M
| $9.20 | $20 |
117%
upside
| Buy |
18 Mar ‘25
5 months ago |
|
|
VRNA
10
Verona Pharma
VRNA
$9.2B
| $106.40 | $68 |
36%
downside
| Buy |
10 Jan ‘25
8 months ago |
|
|
11
Cingulate
CING
$20.8M
| $3.93 | $12 |
205%
upside
| Buy |
10 Jan ‘25
8 months ago |
|
|
12
Reviva Pharmaceuticals
RVPH
$30.1M
| $0.4431 | $7 |
1,480%
upside
| Buy |
10 Jan ‘25
8 months ago |
|
|
13
Gain Therapeutics
GANX
$62.2M
| $1.72 | $7 |
307%
upside
| Buy |
24 Dec ‘24
8 months ago |
|
14
Entrada Therapeutics
TRDA
$199M
| $5.33 | $29 |
444%
upside
| Buy |
5 Dec ‘24
9 months ago |
|
|
LGVN
15
Longeveron
LGVN
$16.6M
| $0.7950 | $10 |
1,158%
upside
| Buy |
5 Dec ‘24
9 months ago |
|